(-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization.

(-)-Epigallocatechin-3-gallate (EGCG) is the most extensive studied tea polyphenol for its anti-cancer function. In this study, we report a novel mechanism of action for EGCG-mediated cell death by identifying the critical role of lysosomal membrane permeabilization (LMP). First, EGCG-induced cell d...

Full description

Bibliographic Details
Main Authors: Yin Zhang, Nai-Di Yang, Fan Zhou, Ting Shen, Ting Duan, Jing Zhou, Yin Shi, Xin-Qiang Zhu, Han-Ming Shen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3466311?pdf=render
id doaj-c78463156c534aa083902fd73f0a057e
record_format Article
spelling doaj-c78463156c534aa083902fd73f0a057e2020-11-25T01:08:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01710e4674910.1371/journal.pone.0046749(-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization.Yin ZhangNai-Di YangFan ZhouTing ShenTing DuanJing ZhouYin ShiXin-Qiang ZhuHan-Ming Shen(-)-Epigallocatechin-3-gallate (EGCG) is the most extensive studied tea polyphenol for its anti-cancer function. In this study, we report a novel mechanism of action for EGCG-mediated cell death by identifying the critical role of lysosomal membrane permeabilization (LMP). First, EGCG-induced cell death in human cancer cells (both HepG2 and HeLa) was found to be caspase-independent and accompanied by evident cytosolic vacuolization, only observable when cells were treated in serum-free medium. The cytosolic vacuolization observed in EGCG-treated cells was most probably caused by lysosomal dilation. Interestingly, EGCG was able to disrupt autophagic flux at the degradation stage by impairment of lysosomal function, and EGCG-induced cell death was independent of Atg5 or autophagy. The key finding of this study is that EGCG is able to trigger LMP, as evidenced by Lyso-Tracker Red staining, cathepsin D cytosolic translocation and cytosolic acidification. Consistently, a lysosomotropic agent, chloroquine, effectively rescues the cell death via suppressing LMP-caused cytosolic acidification. Lastly, we found that EGCG promotes production of intracellular ROS upstream of LMP and cell death, as evidenced by increased level of ROS in cells treated with EGCG and the protective effects of antioxidant N-acetylcysteine (NAC) against EGCG-mediated LMP and cell death. Taken together, data from our study reveal a novel mechanism underlying EGCG-induced cell death involving ROS and LMP. Therefore, understanding this lysosome-associated cell death pathway shed new lights on the anti-cancer effects of EGCG.http://europepmc.org/articles/PMC3466311?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Yin Zhang
Nai-Di Yang
Fan Zhou
Ting Shen
Ting Duan
Jing Zhou
Yin Shi
Xin-Qiang Zhu
Han-Ming Shen
spellingShingle Yin Zhang
Nai-Di Yang
Fan Zhou
Ting Shen
Ting Duan
Jing Zhou
Yin Shi
Xin-Qiang Zhu
Han-Ming Shen
(-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization.
PLoS ONE
author_facet Yin Zhang
Nai-Di Yang
Fan Zhou
Ting Shen
Ting Duan
Jing Zhou
Yin Shi
Xin-Qiang Zhu
Han-Ming Shen
author_sort Yin Zhang
title (-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization.
title_short (-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization.
title_full (-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization.
title_fullStr (-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization.
title_full_unstemmed (-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization.
title_sort (-)-epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ros-mediated lysosomal membrane permeabilization.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description (-)-Epigallocatechin-3-gallate (EGCG) is the most extensive studied tea polyphenol for its anti-cancer function. In this study, we report a novel mechanism of action for EGCG-mediated cell death by identifying the critical role of lysosomal membrane permeabilization (LMP). First, EGCG-induced cell death in human cancer cells (both HepG2 and HeLa) was found to be caspase-independent and accompanied by evident cytosolic vacuolization, only observable when cells were treated in serum-free medium. The cytosolic vacuolization observed in EGCG-treated cells was most probably caused by lysosomal dilation. Interestingly, EGCG was able to disrupt autophagic flux at the degradation stage by impairment of lysosomal function, and EGCG-induced cell death was independent of Atg5 or autophagy. The key finding of this study is that EGCG is able to trigger LMP, as evidenced by Lyso-Tracker Red staining, cathepsin D cytosolic translocation and cytosolic acidification. Consistently, a lysosomotropic agent, chloroquine, effectively rescues the cell death via suppressing LMP-caused cytosolic acidification. Lastly, we found that EGCG promotes production of intracellular ROS upstream of LMP and cell death, as evidenced by increased level of ROS in cells treated with EGCG and the protective effects of antioxidant N-acetylcysteine (NAC) against EGCG-mediated LMP and cell death. Taken together, data from our study reveal a novel mechanism underlying EGCG-induced cell death involving ROS and LMP. Therefore, understanding this lysosome-associated cell death pathway shed new lights on the anti-cancer effects of EGCG.
url http://europepmc.org/articles/PMC3466311?pdf=render
work_keys_str_mv AT yinzhang epigallocatechin3gallateinducesnonapoptoticcelldeathinhumancancercellsviarosmediatedlysosomalmembranepermeabilization
AT naidiyang epigallocatechin3gallateinducesnonapoptoticcelldeathinhumancancercellsviarosmediatedlysosomalmembranepermeabilization
AT fanzhou epigallocatechin3gallateinducesnonapoptoticcelldeathinhumancancercellsviarosmediatedlysosomalmembranepermeabilization
AT tingshen epigallocatechin3gallateinducesnonapoptoticcelldeathinhumancancercellsviarosmediatedlysosomalmembranepermeabilization
AT tingduan epigallocatechin3gallateinducesnonapoptoticcelldeathinhumancancercellsviarosmediatedlysosomalmembranepermeabilization
AT jingzhou epigallocatechin3gallateinducesnonapoptoticcelldeathinhumancancercellsviarosmediatedlysosomalmembranepermeabilization
AT yinshi epigallocatechin3gallateinducesnonapoptoticcelldeathinhumancancercellsviarosmediatedlysosomalmembranepermeabilization
AT xinqiangzhu epigallocatechin3gallateinducesnonapoptoticcelldeathinhumancancercellsviarosmediatedlysosomalmembranepermeabilization
AT hanmingshen epigallocatechin3gallateinducesnonapoptoticcelldeathinhumancancercellsviarosmediatedlysosomalmembranepermeabilization
_version_ 1725183014875430912